OR (95 % CI), all patients, n = 1110 | P value | OR (95 % CI), hospital survivors, n = 1053 | P value | |
---|---|---|---|---|
NIHSS at admission | ||||
≤ 5 | Reference | Reference | ||
6–10 | 2.52 (1.80–3.54) | < 0.001 | 2.75 (1.94–3.89) | < 0.001 |
11–15 | 8.69 (5.02–15.0) | < 0.001 | 9.92 (5.59–17.61) | < 0.001 |
16–20 | 8.70 (4.80–15.8) | < 0.001 | 10.12 (5.36–19.10) | < 0.001 |
> 20 | 5.82 (3.69–9.18) | < 0.001 | 16.99 (8.97–32.19) | < 0.001 |
Atrial fibrillation | 1.37 (0.95–1.97) | 0.087 | 1.68 (1.12–2.51) | 0.011 |
Oral anticoagulant | 0.39 (0.18–0.83) | 0.015 | 0.30 (0.13–0.69) | 0.005 |
Leukocytosis (> 10 × 109 cells/L) at admission | 1.50 (1.07–2.11) | 0.020 | 1.59 (1.10–2.29) | 0.013 |
Intravenous thrombolysis | 0.48 (0.33–0.71) | < 0.001 | 0.42 (0.27–0.64) | < 0.001 |